Maintenance of Viability and Function of Rat Islets With the Use of ROCK Inhibitor Y-27632

Area of Science:

• Endocrinology
• Cell Biology
• Regenerative Medicine

Background:

• Diabetes mellitus is a growing global health concern, with type 1 diabetes often managed through islet transplantation.
• Islet transplantation aims to restore glucose homeostasis but faces challenges with graft survival and function.
• Maintaining islet viability and function during culture is critical for successful transplantation outcomes.

Purpose of the Study:

• To evaluate the efficacy of Rho-associated protein kinase (ROCK) inhibitor Y-27632 in preserving the morphology, viability, and function of freshly isolated rat islets in vitro.
• To determine if Y-27632 can enhance insulin secretion and inhibit apoptosis in cultured islets.

Main Methods:

• Rat islets were isolated from Lewis rats and cultured in two groups: one with Y-27632 and a control group without.
• Islet morphology, cell viability, and insulin secretion were assessed on day seven of culture.
• Apoptosis markers (Bcl-2 and Bax) were analyzed to confirm the anti-apoptotic effects of Y-27632.

Main Results:

• Islets cultured with Y-27632 exhibited significantly better morphological maintenance compared to the control group.
• Y-27632 treatment led to increased expression of Bcl-2 and decreased expression of Bax, confirming apoptosis inhibition.
• Islets treated with Y-27632 demonstrated predominantly enhanced insulin secretion.

Conclusions:

• ROCK inhibitor Y-27632 effectively maintains the morphological and functional integrity of cultured rat islets.
• Y-27632 demonstrates anti-apoptotic properties and promotes insulin secretion, suggesting its utility in improving islet graft survival and function for transplantation.
• This study highlights Y-27632 as a promising agent for enhancing islet culture and transplantation protocols for diabetes management.